Literature DB >> 1684951

Assignment of the human prohibitin gene (PHB) to chromosome 17 and identification of a DNA polymorphism.

J J White1, D H Ledbetter, R L Eddy, T B Shows, D A Stewart, M J Nuell, V Friedman, C M Wood, G A Owens, J K McClung.   

Abstract

Prohibition is a recently identified antiproliferative protein whose exact role in the cell is under investigation. To determine the human chromosomal location of the prohibition gene (PHB) and whether this site corresponds to that of any suspected tumor suppressor gene, we have analyzed DNA from three sources by hybridization analysis: mouse--human hybrid cell lines, hybrid cell lines containing portions of human chromosomes, and human metaphase chromosomes in situ. All three techniques confirm a location in the region 17q21-q22, a region genetically linked to early-onset human breast cancer. Further analysis will be required to establish the significance of this relationship; Southern hybridizations show a polymorphic EcoRI site that may be useful for this purpose.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684951     DOI: 10.1016/0888-7543(91)90126-y

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

1.  A somatic cell hybrid map of the long arm of human chromosome 17, containing the familial breast cancer locus (BRCA1).

Authors:  D M Black; H Nicolai; J Borrow; E Solomon
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

2.  Prohibitin: a potential biomarker for tissue-based detection of gastric cancer.

Authors:  Xiangdong Kang; Long Zhang; Jian Sun; Zhenhua Ni; Yanchun Ma; Xiaobo Chen; Xia Sheng; Teng Chen
Journal:  J Gastroenterol       Date:  2008-08-17       Impact factor: 7.527

3.  Roles of prohibitin in growth control and tumor suppression in human cancers.

Authors:  Sheng Wang; Douglas V Faller
Journal:  Transl Oncogenomics       Date:  2008-02-10

4.  Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.

Authors:  A Jakubowska; D Rozkrut; A Antoniou; U Hamann; R J Scott; L McGuffog; S Healy; O M Sinilnikova; G Rennert; F Lejbkowicz; A Flugelman; I L Andrulis; G Glendon; H Ozcelik; M Thomassen; M Paligo; P Aretini; J Kantala; B Aroer; A von Wachenfeldt; A Liljegren; N Loman; K Herbst; U Kristoffersson; R Rosenquist; P Karlsson; M Stenmark-Askmalm; B Melin; K L Nathanson; S M Domchek; T Byrski; T Huzarski; J Gronwald; J Menkiszak; C Cybulski; P Serrano; A Osorio; T R Cajal; M Tsitlaidou; J Benítez; M Gilbert; M Rookus; C M Aalfs; I Kluijt; J L Boessenkool-Pape; H E J Meijers-Heijboer; J C Oosterwijk; C J van Asperen; M J Blok; M R Nelen; A M W van den Ouweland; C Seynaeve; R B van der Luijt; P Devilee; D F Easton; S Peock; D Frost; R Platte; S D Ellis; E Fineberg; D G Evans; F Lalloo; R Eeles; C Jacobs; J Adlard; R Davidson; D Eccles; T Cole; J Cook; A Godwin; B Bove; D Stoppa-Lyonnet; V Caux-Moncoutier; M Belotti; C Tirapo; S Mazoyer; L Barjhoux; N Boutry-Kryza; P Pujol; I Coupier; J-P Peyrat; P Vennin; D Muller; J-P Fricker; L Venat-Bouvet; O Th Johannsson; C Isaacs; R Schmutzler; B Wappenschmidt; A Meindl; N Arnold; R Varon-Mateeva; D Niederacher; C Sutter; H Deissler; S Preisler-Adams; J Simard; P Soucy; F Durocher; G Chenevix-Trench; J Beesley; X Chen; T Rebbeck; F Couch; X Wang; N Lindor; Z Fredericksen; V S Pankratz; P Peterlongo; B Bonanni; S Fortuzzi; B Peissel; C Szabo; P L Mai; J T Loud; J Lubinski
Journal:  Br J Cancer       Date:  2012-05-15       Impact factor: 7.640

Review 5.  Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.

Authors:  Jie Yang; Bin Li; Qing-Yu He
Journal:  Cell Death Dis       Date:  2018-05-21       Impact factor: 8.469

Review 6.  Prohibitins: A Key Link between Mitochondria and Nervous System Diseases.

Authors:  Tianlin Jiang; Jiahua Wang; Chao Li; Guiyun Cao; Xiaohong Wang
Journal:  Oxid Med Cell Longev       Date:  2022-07-08       Impact factor: 7.310

7.  The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein.

Authors:  M Terashima; K M Kim; T Adachi; P J Nielsen; M Reth; G Köhler; M C Lamers
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

8.  Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma.

Authors:  A Swift; J M Risk; A N Kingsnorth; T A Wright; M Myskow; J K Field
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

Review 9.  Prohibitin: a potential therapeutic target in tyrosine kinase signaling.

Authors:  Sudharsana Rao Ande; Yang Xin Zi Xu; Suresh Mishra
Journal:  Signal Transduct Target Ther       Date:  2017-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.